Viromed Medical AG Cash Flow Reinvestment Rate
Latest as of December 2024:
4.82x
Viromed Medical AG cash flow reinvestment rate. Viromed Medical AG (Q11) has a Cash Flow Reinvestment Rate of 4.82x as of December 2024, reinvesting €35.91 Million (capex €35.91 Million ) from operating cash flow of €7.45 Million. Explore Viromed Medical AG (Q11) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
4.82x
(Capex + Investments) / Operating CF
Total Reinvested
€35.91 Million
Capex + Investments
Operating Cash Flow
€7.45 Million
EUR
Capital Expenditures
€35.91 Million
EUR
Viromed Medical AG Cash Flow Reinvestment Rate by Year (None–None)
Viromed Medical AG cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Viromed Medical AG. For the full cash flow conversion analysis, see cash efficiency ratio of Viromed Medical AG.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow